WO2012033614A2 - Dispositif de pression positive des voies respiratoires continues nasales pour réduire l'effort de respiration - Google Patents

Dispositif de pression positive des voies respiratoires continues nasales pour réduire l'effort de respiration Download PDF

Info

Publication number
WO2012033614A2
WO2012033614A2 PCT/US2011/047965 US2011047965W WO2012033614A2 WO 2012033614 A2 WO2012033614 A2 WO 2012033614A2 US 2011047965 W US2011047965 W US 2011047965W WO 2012033614 A2 WO2012033614 A2 WO 2012033614A2
Authority
WO
WIPO (PCT)
Prior art keywords
pathway
jet
towards
gas
ncpap
Prior art date
Application number
PCT/US2011/047965
Other languages
English (en)
Other versions
WO2012033614A3 (fr
Inventor
Khalid Mansour
Original Assignee
Carefusion 303, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carefusion 303, Inc. filed Critical Carefusion 303, Inc.
Priority to BR112013005035-7A priority Critical patent/BR112013005035B1/pt
Priority to AU2011299456A priority patent/AU2011299456B2/en
Priority to EP11823937.5A priority patent/EP2613831B1/fr
Priority to JP2013528212A priority patent/JP5903099B2/ja
Priority to CA2809817A priority patent/CA2809817C/fr
Priority to ES11823937T priority patent/ES2774950T3/es
Priority to NZ607273A priority patent/NZ607273A/en
Priority to RU2013109241/14A priority patent/RU2567601C2/ru
Priority to MX2013002438A priority patent/MX339752B/es
Publication of WO2012033614A2 publication Critical patent/WO2012033614A2/fr
Publication of WO2012033614A3 publication Critical patent/WO2012033614A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0666—Nasal cannulas or tubing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/20—Flow characteristics having means for promoting or enhancing the flow, actively or passively

Definitions

  • the present technology relates generally to the respiratory field. More particularly, the present technology relates to a variable flow nasal continuous positive airway pressure device. In more detail, the technology relates to a nasal continuous positive airway pressure device for lowering patient work-of-breathing.
  • CPAP continuous positive airway pressure
  • CPAP is a method of respiratory ventilation used primarily to treat patients experiencing respiratory difficulties and/or insufficiencies.
  • CPAP is used for critically ill patients in a hospital with respiratory failure.
  • PAP ventilation can prevent the need for tracheal intubation, or allow earlier extubation.
  • patients with neuromuscular diseases use this variety of ventilation as well.
  • nCPAP nasal continuous positive airway pressure
  • Figure 1 is a perspective view of a nasal continuous positive airway pressure device for lowering patient work-of-breathing, according to one embodiment of the present technology.
  • Figure 2 is a perspective view of a flow enhancer of a generator body of a nasal continuous positive airway pressure device for lowering patient work-of-breathing, according to one embodiment of the present technology.
  • Figure 3 is a flow diagram of a method for delivering a nasal continuous positive airway pressure to a patient, according to one embodiment of the present technology.
  • nasal continuous positive airway pressure (nCPAP) devices assist infants with under-developed lungs by preventing lung collapse during exhalation and assisting in lung expansion during inhalation.
  • One type of interface device that couples the generator body of a nCPAP with the infant are nasal prongs.
  • a relative constant and continuous flow of gas e.g., air, 02, etc.
  • This airflow creates a pressure within a patient's lungs via a restriction placed on outflow from the patient.
  • the patient is required to exhale against the incoming gas, which increases the patient's work of breathing (WOB).
  • Embodiments of the present technology provide a nasal continuous positive airway pressure (nCPAP) device for lowering a patient's WOB.
  • nCPAP nasal continuous positive airway pressure
  • the flow enhancer of the nCPAP device redirects a jet flow of gas that was originally directed towards a patient's nares to a jet impingement point. Channeling the dual jet flows into a common jet flow that is moving toward the patient's nares enables the patient to more easily inhale the oxygen, and thus decreases WOB.
  • the flow enhancer of the nCPAP device directs a first portion of the exhaled patient breath towards the channeled jet flow directed at the jet impingement point. Directing the exhaled breath to meet this channeled jet flow head on causes, through a "fluidic flip" effect, the channeled jet flow (airstream) directed towards the patient's nares to reverse direction. Thus, both the channeled jet flow now traveling in the reverse direction and the exhaled patient breath now flow to the expiratory tubing. Thus, by causing the jetstream directed towards the patient's nares to reverse direction during the patient's exhalation, the patient does not have to expend lung energy exhaling into an continuously incoming stream of air. Consequently, reversing the direction of the jetstream during the first part of the patient's exhalation lowers the patient's WOB.
  • the flow enhancer of the nCPAP device directs a second portion of the exhaled patient breath along a pathway, separate and isolated from the pathway caused by the "fluidic flip" effect, towards the expiratory tubing.
  • This second portion does not encounter resistance as it flows to the expiratory tubing. Consequently, since the patient does not have to breath the second portion of exhaled air into any incoming airstream, the resistance to exhaled patient breath is lowered, thus lowering the patient's WOB.
  • embodiments of the present technology provide for a method of lowering the patient's WOB by increasing an airflow to the patient during patient inhalation as well as reducing resistances to the patient's exhalation.
  • Figure 1 is a perspective view of a nasal continuous positive airway pressure (nCPAP) device for lowering patient WOB, in accordance with embodiments of the present technology.
  • Figure 2 is a perspective view of a flow enhancer of a generator body of a nCPAP device for lowering patient WOB, in accordance with one embodiment of the present technology.
  • nCPAP nasal continuous positive airway pressure
  • the nCPAP device 100 includes inspiratory tubing 102 in fluid communication with at least two nasal prongs 104, expiratory tubing 106, and a generator body 108 coupled with the inspiratory and expiratory tubing, 102 and 106, respectively.
  • the inspiratory tubing 102 is coupled with a ventilator 134.
  • the at least two nasal prongs 104 are positioned within nare of a patient. It should be appreciated that the term
  • inspiratory tubing may refer to an “inspiratory limb”, as is also used herein.
  • the generator body 108 includes at least two jets 110a and 110b and a flow enhancer 112.
  • the at least two jets 110a and 1 10b are configured for receiving gas 111 from the inspiratory tubing 102 and directing, via a jet flow 1 13, the gas 111 towards the at least two nasal prongs 104.
  • the at least two jets 110a and 110b have a jet diameter 128 greater than .034 a .
  • the jet diameter 128 is .044 a . It should be appreciated that the larger the jet diameter 128, the slower the jet flow 113.
  • the at least two jet paths 118a and 118b are situated angularly with respect to each other. In other words, the jet paths 1 18a and 1 18b, are not parallel with each other.
  • the flow enhancer 112 is configured for redirecting the gas 111 of the jet flow 113.
  • the flow enhancer 1 12 is spaced a distance apart from an interior surface 132 of the generator body 108 to accommodate the second pathway 126. While it is shown in Figure 1 that the expiratory tubing 106 is on top of the generator body 108, it should be appreciated that the expiratory tubing may be coupled with other areas of the generator body 108. For example, the expiratory tubing 106 may be coupled with the generator body 108 next to the flow enhancer 112. In this case, the exhaled patient's breath traveling along second pathway 126, exits the expiratory tubing 106 while next to the flow enhancer 1 12.
  • the flow enhancer 112 circles around the interior surface 132 of the generator body 108.
  • the length of the flow enhancer 112 as viewed form Figure 1 may vary.
  • the thickness of the flow enhancer 112 may be any thickness that is compatible with the nCPAP device that functions to lower the patient's WOB.
  • the flow enhancer 112 is positioned in parallel with a nare path of a patient.
  • the nare path of the patient is also parallel with the nasal prongs 104 of the nCPAP device 100 since the nasal prongs 104 are inserted into the patient's nares for functioning.
  • the flow enhancer 1 12 includes at least one of the following: a gas manager 114; a fluidic flip trigger 120 and an isolated pathway manager 124.
  • the gas manager 114 is configured for channeling 115 the j et flow 113 towards a j et impingement point 116 via at least two j et paths 118a and 1 18b.
  • the fluidic flip trigger 120 is configured for triggering a fluidic flip 121 of channeled gas back towards the expiratory tubing 106.
  • the fluidic flip 121 is triggered by directing 123 a first portion of the exhaled patient breath towards the jet impingement point 116 along a first pathway 122.
  • the isolated pathway manager 124 is configured for directing 125 a second portion of the exhaled patient breath along a second pathway 126 towards the expiratory tubing 106, the second pathway 126 isolated from the first pathway 122.
  • embodiments of the present technology provide for a nCPAP device for lowering a patient's WOB. This is accomplished by reducing resistances throughout the generator body 108 to patient's inhalation and exhalation.
  • FIG. 3 is a flow diagram of a method 300 for delivering a nasal continuous positive airway pressure to a patient, according to one embodiment of the present technology.
  • jet gas 11 1 is directed from at least two jets 110a and 110b towards a patient's nares along at least two jet paths 118a and 118b to meet at a jet impingement point 1 16.
  • a fluidic flip 121 of jet gas flow back towards an expiratory limb 106 is triggered by directing 123 a first portion of exhaled patient breath towards the jet impingement point 116.
  • a second portion of the exhaled patient breath is directed 125 through an isolated path towards the expiratory limb 106.
  • the foregoing method 300 lowers a patient's WOB by providing a jet gas entrainment toward the expiratory limb 106 for the first portion of the exhaled patient breath and an unobstructed flow path for the second portion of the exhaled patient breath.
  • a nasal continuous positive airway pressure (nCPAP) device for lowering patient work-of-breathing comprising:
  • inspiratory tubing in fluid communication with at least two nasal prongs
  • At least two jets configured for receiving gas from said inspiratory tubing and directing, via a jet flow, said gas towards said at least two nasal prongs; and a flow enhancer configured for redirecting said jet flow, said flow enhancer comprising:
  • a gas manager configured for channeling said jet flow towards a jet impingement point via at least two jet paths
  • a fluidic flip trigger configured for triggering a fluidic flip of channeled gas back towards said expiratory tubing by directing a first portion of exhaled patient breath towards said jet impingement point along a first pathway;
  • an isolated pathway manager configured for directing a second portion of said exhaled patient breath along a second pathway towards said expiratory tubing, said second pathway isolated from said first pathway.
  • a method for delivering a nasal continuous positive airway pressure to a patient comprising:
  • a gas manager configured for redirecting a jet flow of gas towards a jet
  • a fluidic flip trigger configured for triggering a fluidic flip of redirected gas back towards a expiratory limb by directing a first portion of exhaled patient breath towards said jet impingement point along a first pathway;
  • an isolated pathway manager configured for directing a second portion of said exhaled patient breath through a second pathway towards said expiratory limb, said second pathway isolated from said first pathway.
  • a nasal continuous positive airway pressure (nCPAP) device for use in an nCPAP system for lowering patient work-of-breathing, said nCPAP device comprising: at least two inspiratory limbs coupled with a ventilator and in fluid communication with a pair of nasal prongs;
  • a generator body coupled with said at least two inspiratory limbs and configured for conveying gas received from said at least two inspiratory limbs to said pair of nasal prongs, said generator body comprising:
  • a flow enhancer configured for redirecting gas moving within said generator body to a pathway of lesser resistance, thereby lowering said patient work-of-breathing; and an expiratory limb coupled with said generator body, said expiratory limb configured for receiving and expelling exhaled patient breath.
  • a fluidic flip trigger configured for triggering a fluidic flip of channeled gas back towards said expiratory limb by directing a first portion of exhaled patient breath towards said jet impingement point along a first pathway.
  • an isolated pathway manager configured for directing a second portion of said exhaled patient breath through a second pathway towards said expiratory limb, said second pathway isolated from said first pathway.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

L'invention porte sur un dispositif de pression positive des voies respiratoires continues nasales, destiné à réduire l'effort de respiration d'un patient, lequel dispositif comprend : un tubage inspiratoire en communication fluidique avec au moins deux canules nasales ; un tubage expiratoire ; et un corps générateur accouplé entre les deux tubages, le corps générateur comprenant : au moins deux buses destinées à recevoir un gaz du tubage inspiratoire ; et un accélérateur d'écoulement destiné à diriger le gaz reçu, l'accélérateur d'écoulement comprenant : un gestionnaire de gaz configuré pour canaliser le gaz reçu vers un point de frappe de buse par l'intermédiaire d'au moins deux trajets de buse ; un déclencheur de flip fluidique conçu pour déclencher un flip fluidique de gaz canalisé renvoyé vers le tubage expiratoire en dirigeant une première partie de la respiration exhalée du patient vers le point de frappe de buse le long d'un premier trajet ; et un gestionnaire de trajet isolé destiné à diriger une seconde partie de la respiration exhalée du patient le long d'un second trajet vers le tubage expiratoire, le second trajet étant isolé du premier trajet.
PCT/US2011/047965 2010-09-10 2011-08-16 Dispositif de pression positive des voies respiratoires continues nasales pour réduire l'effort de respiration WO2012033614A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
BR112013005035-7A BR112013005035B1 (pt) 2010-09-10 2011-08-16 dispositivo de pressão positiva contínua nas vias aéreas nasais (ncpap), método de aplicação de uma pressão positiva contínua nas vias aéreas nasais de um paciente e otimizador de fluxo para uso em um dispositivo de pressão positiva contínua nas vias aéreas nasais
AU2011299456A AU2011299456B2 (en) 2010-09-10 2011-08-16 nCPAP to lower breathing effort
EP11823937.5A EP2613831B1 (fr) 2010-09-10 2011-08-16 Dispositif de pression positive des voies respiratoires continues nasales pour réduire l'effort de respiration
JP2013528212A JP5903099B2 (ja) 2010-09-10 2011-08-16 呼吸努力を低減するためのｎＣＰＡＰ
CA2809817A CA2809817C (fr) 2010-09-10 2011-08-16 Dispositif de pression positive des voies respiratoires continues nasales pour reduire l'effort de respiration
ES11823937T ES2774950T3 (es) 2010-09-10 2011-08-16 Presión positiva continua en las vías aéreas nasales para reducir el esfuerzo de respiración
NZ607273A NZ607273A (en) 2010-09-10 2011-08-16 Ncpap to lower breathing effort
RU2013109241/14A RU2567601C2 (ru) 2010-09-10 2011-08-16 СПОСОБ СОЗДАНИЯ ПОСТОЯННОГО НОСОВОГО ПОЛОЖИТЕЛЬНОГО ДАВЛЕНИЯ В ДЫХАТЕЛЬНЫХ ПУТЯХ nCPAP ДЛЯ УМЕНЬШЕНИЯ ДЫХАТЕЛЬНОГО УСИЛИЯ
MX2013002438A MX339752B (es) 2010-09-10 2011-08-16 Ncpap para disminuir el esfuerzo respiratorio.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/880,041 2010-09-10
US12/880,041 US8813746B2 (en) 2010-09-10 2010-09-10 Nasal continuous positive airway pressure device for lowering patient work-of-breathing

Publications (2)

Publication Number Publication Date
WO2012033614A2 true WO2012033614A2 (fr) 2012-03-15
WO2012033614A3 WO2012033614A3 (fr) 2012-07-12

Family

ID=45805454

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/047965 WO2012033614A2 (fr) 2010-09-10 2011-08-16 Dispositif de pression positive des voies respiratoires continues nasales pour réduire l'effort de respiration

Country Status (11)

Country Link
US (1) US8813746B2 (fr)
EP (1) EP2613831B1 (fr)
JP (1) JP5903099B2 (fr)
BR (1) BR112013005035B1 (fr)
CA (1) CA2809817C (fr)
ES (1) ES2774950T3 (fr)
MX (1) MX339752B (fr)
NZ (1) NZ607273A (fr)
RU (1) RU2567601C2 (fr)
TW (1) TWI564003B (fr)
WO (1) WO2012033614A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3552649B1 (fr) 2015-04-02 2023-08-23 Hill-Rom Services PTE. LTD. Commande de pression de dispositif respiratoire
CN113260401A (zh) * 2018-10-19 2021-08-13 D-Rev：专为其他百分之九十设计公司 用于新生儿的改进的持续气道正压通气装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090301495A1 (en) 2005-12-02 2009-12-10 Brian Pierro Nasal continuous positive airway pressure device and system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462614B (sv) * 1988-12-06 1990-07-30 Conny Peder Gunnar Moa Anordning foer att genom ejektorverkan generera kontinuerligt positivt luftvaegstryck vid spontanandning
US5975077A (en) * 1998-07-28 1999-11-02 Hamilton Medical, Inc. Method and apparatus for assisting in breathing
US20030200970A1 (en) * 2002-04-29 2003-10-30 Alex Stenzler Infant breathing assist apparatus
US20060180149A1 (en) * 2003-07-22 2006-08-17 Hasdi Matarasso A respiratory aid system and method
US7406966B2 (en) * 2003-08-18 2008-08-05 Menlo Lifesciences, Llc Method and device for non-invasive ventilation with nasal interface
US8100125B2 (en) 2005-09-30 2012-01-24 Carefusion 207, Inc. Venturi geometry design for flow-generator patient circuit
US8006692B2 (en) * 2005-12-02 2011-08-30 Carefusion 2200, Inc. Gas blender with auxiliary mixed gas outlet
JP4710015B2 (ja) * 2006-03-01 2011-06-29 国立大学法人埼玉大学 ネーザルｃｐａｐ素子
EP2231244B1 (fr) * 2007-12-19 2016-06-01 Neores AB Dispositif de nébulisation destiné à être utilisé dans un système de pression positive continue des voies aériennes
US8210182B2 (en) 2007-12-28 2012-07-03 Carefusion 207, Inc. Continuous positive airway pressure device
RU2357762C1 (ru) * 2008-01-31 2009-06-10 Общество с ограниченной ответственностью "ВентАрт" Аппарат искусственной вентиляции легких

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090301495A1 (en) 2005-12-02 2009-12-10 Brian Pierro Nasal continuous positive airway pressure device and system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2613831A4

Also Published As

Publication number Publication date
NZ607273A (en) 2015-01-30
MX2013002438A (es) 2013-08-29
RU2567601C2 (ru) 2015-11-10
AU2011299456A1 (en) 2013-03-21
CA2809817A1 (fr) 2012-03-15
WO2012033614A3 (fr) 2012-07-12
TW201216947A (en) 2012-05-01
BR112013005035B1 (pt) 2021-01-12
ES2774950T3 (es) 2020-07-23
TWI564003B (zh) 2017-01-01
EP2613831A2 (fr) 2013-07-17
JP2013537061A (ja) 2013-09-30
RU2013109241A (ru) 2014-09-10
EP2613831A4 (fr) 2017-09-20
JP5903099B2 (ja) 2016-04-13
US20120060844A1 (en) 2012-03-15
EP2613831B1 (fr) 2019-12-11
BR112013005035A2 (pt) 2017-07-18
MX339752B (es) 2016-06-08
CA2809817C (fr) 2019-10-15
US8813746B2 (en) 2014-08-26

Similar Documents

Publication Publication Date Title
US11364358B2 (en) Nasal cannula for continuous and simultaneous delivery of aerosolized medicament and high flow therapy
EP2691137B1 (fr) Dispositif de mise sous pression positive des voies respiratoires continues à division de flux
US5690097A (en) Combination anesthetic mask and oxygen transport system
EP2326376B1 (fr) Dispositifs pour fournir une ventilation mécanique avec une interface de voies respiratoires ouvertes
EP3471813B1 (fr) Systèmes d'assistance à la toux ayant une dérivation d'humidificateur
US11590312B2 (en) Respiratory therapy condensation adaptor
JP2013503720A5 (fr)
CA2809817C (fr) Dispositif de pression positive des voies respiratoires continues nasales pour reduire l'effort de respiration
AU2011299456B2 (en) nCPAP to lower breathing effort
JP2013537061A5 (fr)
US20130319413A1 (en) Reducing sound level in a respiratory gas delivery system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11823937

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2809817

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2013/002438

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2013109241

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2013528212

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2011823937

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2011299456

Country of ref document: AU

Date of ref document: 20110816

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013005035

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013005035

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130301